Key facts
- Canaccord lowered the stock price target for Boston Scientific.
- The price target reduction was due to a slowdown in Watchman sales.
- Concerns about the performance of the Watchman device were cited.
Analyst price target changes often reflect updated views on a company's financial performance and future prospects. Revisions to sales figures or product performance can signal shifts in revenue and profitability, impacting investor sentiment and stock valuation.